| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |